Drug Type Recombinant vector vaccine, Prophylactic vaccine |
Synonyms HPV16 Ad26-vectored vaccine, Monovalent HPV16 + [1] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HPV16 Infection | Phase 2 | Belgium | 27 Sep 2018 | |
| HPV16 Infection | Phase 2 | United States | 27 Sep 2018 | |
| HPV16 Infection | Phase 2 | Belgium | 27 Sep 2018 | |
| HPV16 Infection | Phase 2 | United States | 27 Sep 2018 |





